Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT05237102
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18, gender is not limited.
* Patients with traffic hydrocephalus caused by various reasons, including atmospheric hydrocephalus, who need cerebrospinal fluid shunt and meet the surgical indications to a certain extent.
* Typical imaging manifestations of hydrocephalus patients.
* Clinical manifestations of consciousness disorder.
* Whether or not you can participate in the study will be decided after a doctor's examination.
Exclusion Criteria:
* patients with mental or motor disorders, such as Alzheimer's disease, schizophrenia, and Parkinson's disease.
* Patients with abnormal coagulation mechanism or receiving treatment with thrombolysis agent, anticoagulant or platelet coagulant inhibitor and hemophilia.
* Patients with serious diseases of other systems, such as serious diseases of blood system, respiratory system, digestive system, urinary system and immune system, as well as patients with mental disorders and recent history of intracranial infection.
* Patients with a known disease causing ventricle enlargement.
* Female patients in pregnancy and lactation.
* Other circumstances in which the doctor judges that he cannot participate in the test.
* The subject himself or his legal representative refuses to participate in the clinical trial. Whether you are suitable to participate in this study needs the final decision after doctor's examination.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05237102
Study Brief:
Protocol Section:
NCT05237102